Objectives Primary sclerosing cholangitis (PSC) is a rare chronic disease that presents challenges to both patients and ...

In this referral centre based study, inflammatory bowel disease associated with primary sclerosing cholangitis (PSC-IBD) was characterised by a high prevalence of pancolitis with rectal sparing and ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

Readers respond to the question of how prayer or intention has helped them make it through periods of great physical pain.

作者：陈洁，王雪，李春燕，汤善宏西部战区总医院消化内科自身免疫性肝病（autoimmune liver disease，AILD）主要由包括以肝细胞损伤为主的自身免疫性肝炎（autoimmune ...

Investors' focus will likely be on GILD's HIV franchise performance and oncology sales when the company reports ...

Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury, cholestasis and ...

We read with great interest the study by Wunsch et al 1 published in this issue of Polish Archives of Internal Medicine, which validated the prognostic ability of 2 previously ide ...

Dr. Yeh will oversee the continued clinical development of NGM Bio’s key programs, NGM120 for hyperemesis gravidarum and cancer cachexia, and ...

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.

Pliant Therapeutics, Inc.’s PLRX share price has dipped by 34.81%, which has investors questioning if this is right time to ...

Rare Disease Day is February 28. Primary sclerosing cholangitis or PSC is a rare liver disease characterized by progressive ...